Nanomedicine and Nanotechnology
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
”Nanomedicine and Nanotechnology” is a new section of the peer-reviewed open access journal Pharmaceutics, which is focused on all aspects and applications of innovative nanosystems.
The main aims of this section are to highlight and collect recent progress in nanotechnology and its applications in pharmaceutical, clinical, diagnostic, environmental, and cosmetic fields.
Covered topics include the following:
- Advances in methodologies for characterization of nanocarriers
- Nanodevices and nanosensors
- Stability studies
- Development of new drug delivery systems
- Nanotoxicity
- Skin and mucosal application
- Nanotechnology in tissue engineering and regenerative nanomedicine
- Functionalization for a selective target
- Nanodelivery systems in cosmeceutical and nutraceutical field
- Nanodelivery as a strategy to improve bioavailability
- Strategies and formulations for controlled drug release
- In vivo testing
The section encourages the submission of papers including in vitro and in vivo evidence and clinical data on nanomedicine and nanotechnology fields. Authors will enjoy a high-quality reviewing process, rapid publication, and high visibility from access to a broad readership.
Review, original research papers, communications, short communications, opinions, or technical notes will be considered for publication.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Recent Advances in Nanotechnology-Based Approaches for Pharmaceutical Applications (Deadline: 30 November 2024)
- Drug Nanocarriers for Pharmaceutical Applications (Deadline: 30 November 2024)
- Nanotechnology-Based Drug Delivery Systems, 2nd Edition (Deadline: 30 November 2024)
- Nano-Drug Delivery Technologies for Cancer Immunotherapy (Deadline: 30 November 2024)
- Nanoparticles and Their Influence on Organs through the Gut–Organ Axis: Innovations in Drug Delivery and Gut Microbiota Metabolites (Deadline: 30 November 2024)
- Smart Nanotechnology to Enhancing Drug Delivery and Bioavailability (Deadline: 30 November 2024)
- Application of Nanostructured Lipid Carriers in Antibacterial and Anticancer (Deadline: 30 November 2024)
- Development of New Nanotechnological Systems Loaded with Drugs for Infectious Disease Application (Deadline: 30 November 2024)
- New Delivery Strategy Based on Magnetic Nanoparticles for Disease Treatment (Deadline: 30 November 2024)
- Application of Nanoparticles and Dendrimers for Treating Infectious Diseases (Deadline: 10 December 2024)
- The Role of Nano/Microemulsions in Drug Delivery and Controlled Release (Deadline: 10 December 2024)
- Polymer Nanoparticles for the Delivery of Anticancer Drugs, 3rd Edition (Deadline: 10 December 2024)
- Nanocarrier-Based Antibacterial Agents and Formulations (Deadline: 15 December 2024)
- Lipid Nanostructures as Drug Carriers for Cancer Therapy (Deadline: 20 December 2024)
- Nanoparticles for Liver Diseases Therapy (Deadline: 20 December 2024)
- Carbon Nanomaterials in Pharmaceutical Sciences: Exploring Antibacterial, Antiviral, and Anticancer Properties (Deadline: 20 December 2024)
- Nanoformulations for Local Treatment of Cancer, Infections and Wounds (Deadline: 20 December 2024)
- Application of Nanomedicine in Metabolic and Chronic Diseases (Deadline: 30 December 2024)
- Topical Advisory Panel Members' Collection Series: Nanocarriers for Alternative Drug Delivery (Deadline: 31 December 2024)
- Biomimetic Nanoparticles for Disease Treatment and Diagnosis (Deadline: 31 December 2024)
- Lipid-Based Nanoparticles for Drug Delivery in Cancer (Deadline: 31 December 2024)
- Nanotechnology Applied in Prevention, Diagnosis and Treatment of Cancer (Deadline: 31 December 2024)
- Contribution of Dendrimers and Other Dendritic Polymers in Medical Nanotechnology (Deadline: 31 December 2024)
- Photodynamic, Photothermal and Photoimmune Therapy and Other Antimicrobial Nanomedicine-Related Applications (Deadline: 31 December 2024)
- Nanoparticles for Local Drug Delivery (Deadline: 31 December 2024)
- Micro- and Nanoemulsions in Therapeutics: Advancements in Targeted Drug Delivery and Theranostic Applications (Deadline: 31 December 2024)
- Advances in Nanocarriers for Drug Delivery and Targeting, 2nd Edition (Deadline: 31 December 2024)
- Nanomedicines for Overcoming Tumor Immunotherapy Tolerance (Deadline: 31 December 2024)
- Nano-Enabled Formulations: Recent Insights and Biomedical Applications (Deadline: 31 December 2024)
- Nano-Based Delivery Systems for Topical Applications (Deadline: 31 December 2024)
- Polymer-Based Nanocapsules for Drug Delivery in Cardiovascular Diseases and Metabolic Syndrome (Deadline: 31 December 2024)
- Polymeric Nanoparticles for Pharmaceutical Applications (Deadline: 31 December 2024)
- Nanocomposites as Implantable Devices or Drug Delivery Platforms: A New Insight into Treat Dental and Oral Diseases (Deadline: 31 December 2024)
- Functional Nanomaterials in Pharmaceutics: Current Uses and Potential Applications (Deadline: 31 December 2024)
- Enhancing Cancer Therapeutics: Harnessing Nanoplatforms for Mitochondria-Targeted Drug Delivery (Deadline: 10 January 2025)
- Pharmaceutical Nanotechnology for the Treatment of Leishmaniasis and Chagas Diseases (Deadline: 10 January 2025)
- Metal Nanoparticles for Biomedical Applications (Deadline: 10 January 2025)
- Nanomaterials Application as Drug Delivery Systems to the Treatment of Neurodegenerative Diseases (Deadline: 20 January 2025)
- Research on New Strategies for Tumor Therapy Based on Nanostructured Materials (Deadline: 20 January 2025)
- Stem Cell Therapy and Nanodelivery Systems for Tissue Engineering (Deadline: 20 January 2025)
- Synthesis of Microfluidic-Based Nanoparticles and Their Potential Applications in Drug Delivery Systems (Deadline: 20 January 2025)
- Advances in Oral Delivery of Lipid Nanoparticles for Treating Inflammatory Diseases (Deadline: 20 January 2025)
- Nanoparticles: Technology and Therapeutic Applications in Human Infectious and Parasitic Diseases (Deadline: 25 January 2025)
- Application of Polymeric Nanoparticles in Pulmonary Drug Delivery (Deadline: 31 January 2025)
- Recent Advances in Nanoparticles for Therapy and Diagnosis in Nanomedicine (Deadline: 31 January 2025)
- Applications of Dendrimers in Biomedicine, 2nd Edition (Deadline: 31 January 2025)
- Natural and/or Synthetic-Based Nanostructured Systems as Drug Delivery Platforms (Deadline: 31 January 2025)
- Recent Advances in Nanotechnology Therapeutics (Deadline: 31 January 2025)
- Mesoporous Silica Nanoparticles as Promising Platforms for Therapeutic Application (Deadline: 31 January 2025)
- Emerging Trends in Nanocarriers for Therapeutic and Diagnostic Purposes (Deadline: 31 January 2025)
- Metal Nanoparticles in Therapeutics: Pioneering Drug Delivery Systems and Tissue Engineering (Deadline: 10 February 2025)
- Graphene and Graphene Family Nanomaterials for Biomedical Applications (Deadline: 10 February 2025)
- Smart Nanomedicine for Cancer Diagnosis and Therapy (Deadline: 20 February 2025)
- Functionalized Nanoparticles in Cancer Therapeutics, 2nd Edition (Deadline: 20 February 2025)
- Nanoparticle-Mediated Gene Delivery to Cancer Cells (Deadline: 20 February 2025)
- Innovative Nanoplatforms for Enhanced Gene Delivery and Therapeutic Applications (Deadline: 20 February 2025)
- Precision and Targeted Nanoparticles for Drug Delivery (Deadline: 20 February 2025)
- Research on Protein-Based Nanoparticles and Their Pharmaceutical Applications (Deadline: 20 February 2025)
- Recent Advances in Biomedical Applications of Magnetic Nanomaterials (Deadline: 28 February 2025)
- Biomimetic Nanocarriers for Oral Drug Delivery (Deadline: 28 February 2025)
- The Potential of Silver Nanoparticles in Anti-cancer Therapy (Deadline: 28 February 2025)
- Innovative Nano-Delivery Systems for Enhanced Oral Disease Therapies (Deadline: 28 February 2025)
- Recent Advances in Chitosan-Based Nanoparticles for Drug Delivery (Deadline: 28 February 2025)
- ROS-Mediated Nano Drug Delivery for Antitumor Therapy (Deadline: 28 February 2025)
- Recent Advances in Biogenic-Based Nanostructures for Pharmaceutical Applications (Deadline: 28 February 2025)
- Nanocrystal-Based Targeted Drug Delivery Systems (Deadline: 10 March 2025)
- Hybrid Nanosystems for Anticancer Therapy (Deadline: 20 March 2025)
- Antibacterial Nanoformulations Based on Natural Products (Deadline: 20 March 2025)
- Recent Advances in Pulmonary Inhalation of Nanoformulations (Deadline: 31 March 2025)
- Targeted Nanoradiopharmaceuticals as a Molecular Approach for Theranostic Applications (Deadline: 31 March 2025)
- Antibacterial Applications of Novel Nanoscale Biocompounds (Deadline: 31 March 2025)
- Advanced Nanomaterials for Drug Delivery, 2nd Edition (Deadline: 31 March 2025)
- Biopolymer Materials for Wound Healing, 3rd Edition (Deadline: 31 March 2025)
- Controlled Delivery of Cosmeceuticals Using Nanotechnology (Deadline: 31 March 2025)
- Nanotechnology Advances for Breast Cancer Treatment (Deadline: 31 March 2025)
- Research on Nanomedicine and Delivery Systems Based on Biocompatabible Amphiphilic Materials (Deadline: 31 March 2025)
- Nanofibrous Scaffolds Application in Biomedicine (Deadline: 10 April 2025)
- Functional Nanomaterials for Drug Delivery in Photodynamic Therapy (Deadline: 10 April 2025)
- Synergistic Nanomedicines: Integrating Chemotherapy and Phototherapy for Enhanced Cancer Treatment (Deadline: 10 April 2025)
- Anti-parasitic Applications of Nanoparticles (Deadline: 20 April 2025)
- Advanced Nanotechnology for Combination Therapy and Diagnosis (Deadline: 20 April 2025)
- Nanocomposite Hydrogels and Their Application in Drug Delivery and Tissue Engineering (Deadline: 20 April 2025)
- Drug Nanocarrier for Cancer Treatment (Deadline: 20 April 2025)
- Development of Polymeric Nanoparticles and Lipid Nanoparticles for Nucleic Acid Delivery (Deadline: 20 April 2025)
- Engineering and Characterisation of Novel Nanomedicine Formulations, 2nd Edition (Deadline: 25 April 2025)
- Advances in Nanotechnology-Based Drug Delivery Systems (Deadline: 30 April 2025)
- Advances in Formulation of Nanocarriers for Overcoming Biological Barriers (Deadline: 30 April 2025)
- Application of Silver Nanoparticles in Cancer Treatment (Deadline: 30 April 2025)
- Nano-Based Technology for Glioblastoma (Deadline: 30 April 2025)
- Current Research on Polymeric Nanoparticles for Drug Delivery Applications (Deadline: 30 April 2025)
- Hybrid Nanoparticles for Cancer Therapy (Deadline: 30 April 2025)
- Application of PLGA Nanoparticles in Cancer Therapy (Deadline: 30 April 2025)
- Advancing Block Co-Polymer Nanomedicines: Innovations in Effective Drug Delivery (Deadline: 30 April 2025)
- Nanoemulsions for Nose-to-Brain Drug Delivery (Deadline: 30 April 2025)
- Development of Novel Tumor-Targeting Nanoparticles, 2nd Edition (Deadline: 10 May 2025)
- Natural Nanoparticle for Cancer Diagnosis and Treatment, 2nd Edition (Deadline: 20 May 2025)
- New Nano-Systems for Imaging, Diagnostics, and Drug Delivery (Deadline: 20 May 2025)
- Conjugated Polymer Nanoparticles: Innovative Designs for Photodynamic and Photothermal Therapy in Cancer and Bacterial Infections—Preclinical Evaluation and Beyond (Deadline: 31 May 2025)
- Applications of Nanomaterials in Immunotherapies (Deadline: 31 May 2025)
- Advances and Challenges in Nanomedicine: Translating Nanotechnology into Therapeutics for Cancer, Neurodegenerative, and Infectious Diseases (Deadline: 31 May 2025)
- Multifunctional Nanomaterials in Drug Delivery (Deadline: 31 May 2025)
- New Insights in Nanoparticle-Based Psoriasis and Psoriatic Arthritis Therapy (Deadline: 31 July 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
